secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARVARD BIOSCIENCE INC (HBIO)
CIK:        0001123494
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001171843-25-007071
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HBIO Q3: revenues $20.6M, net loss narrows to $1.2M; Q4 guidance $22.5-$24.5M
-----------------------------------------------------------------------------

- Q3 2025 revenues $20.6M (down 6.4% YoY); gross margin 58.4% vs 58.1%.
- Net loss ($1.2M) vs ($4.8M) YoY; adjusted EBITDA $2.0M vs $1.3M.
- Cash from operations $1.1M positive vs ($0.8M) in Q3 2024.
- Company in active discussions to refinance or repay credit agreement in Q4.
- Q4 guidance: revenues $22.5M-$24.5M, gross margin 58%-60%; cites increased demand and backlog.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1123494/000117184325007071/0001171843-25-007071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1123494/000117184325007071/f8k_110625.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-007071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer